Completed PHASE2 INTERVENTIONAL 2-arm NCT01914627

Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

A Single-centre Randomised, Active-controlled, Observer-blinded, Parallel Group Trial to Evaluate the Efficacy and Safety of a Topical Dimeticone Formulation (Loion®) Compared to 10% Salicylic Acid in the Removal of Scaling in Patients With Chronic Psoriasis Capitis

Sponsor: G. Pohl-Boskamp GmbH & Co. KG

Conditions Scalp Psoriasis

Interventions Dimethicone Salicylic Acid

Updated 5 times since 2017 Last updated: Nov 4, 2014 Started: Aug 31, 2013 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Scalp Psoriasis and is currently completed. G. Pohl-Boskamp GmbH & Co. KG leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

G. Pohl-Boskamp GmbH & Co. KG
Universitätsklinikum Hamburg-Eppendorf

Data source: G. Pohl-Boskamp GmbH & Co. KG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany